Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Mutation Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2018

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

Altman, J. K., Foran, J. M., Pratz, K. W., Trone, D., Cortes, J. E. & Tallman, M. S. Feb 1 2018 In : American Journal of Hematology. 93, 2, p. 213-221 9 p.

Research output: Research - peer-reviewArticle

Consolidation Chemotherapy
Induction Chemotherapy
Acute Myeloid Leukemia
quizartinib
Drug Therapy

Acute myeloid leukemia, version 3.2017: Clinical practice guidelines in oncology

O'Donnell, M. R. , Tallman, M. S. , Abboud, C. N. , Altman, J. K. , Appelbaum, F. R. , Arber, D. A. , Bhatt, V. , Bixby, D. , Blum, W. , Coutre, S. E. , De Lima, M. , Fathi, A. T. , Fiorella, M. , Foran, J. M. , Gore, S. D. , Hall, A. C. , Kropf, P. , Lancet, J. , Maness, L. J. , Marcucci, G. & 14 others Martin, M. G., Moore, J. O., Olin, R., Peker, D., Pollyea, D. A., Pratz, K., Ravandi, F., Shami, P. J., Stone, R. M., Strickland, S. A., Wang, E. S., Wieduwilt, M., Gregory, K. & Ogba, N. Jul 1 2017 In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 7, p. 926-957 32 p.

Research output: Research - peer-reviewReview article

Practice Guidelines
Acute Myeloid Leukemia
Leukemia
Guidelines
Therapeutics

Acute myeloid leukemia in the elderly: therapeutic options and choice

Webster, J. A. & Pratz, K. W. Jun 2 2017 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-14 14 p.

Research output: Research - peer-reviewArticle

Acute Myeloid Leukemia
Therapeutics
Comorbidity
Age Groups
Transplants

Adaptation to TKI treatment reactivates ERK signaling in tyrosine kinase–driven leukemias and other malignancies

Bruner, J. K., Ma, H. S., Li, L., Qin, A. C. R., Rudek, M. A., Jones, R. J., Levis, M. J., Pratz, K. W., Pratilas, C. A. & Small, D. Oct 15 2017 In : Cancer Research. 77, 20, p. 5554-5563 10 p.

Research output: Research - peer-reviewArticle

Protein-Tyrosine Kinases
Leukemia
Neoplasms
Acute Myeloid Leukemia
Mitogen-Activated Protein Kinase Kinases

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Research - peer-reviewArticle

temozolomide
Acute Myeloid Leukemia
Poly(ADP-ribose) Polymerase Inhibitors
veliparib
Methylation